Compass Therapeutics, Inc.
CMPX
$2.25
-$0.01-0.44%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -26.52% | -10.12% | -4.54% | -36.07% | -52.04% |
| Total Depreciation and Amortization | 2.45% | 1.10% | 3.06% | -20.22% | -21.24% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 73.64% | 91.61% | -68.04% | -55.05% | 91.03% |
| Change in Net Operating Assets | 7.91% | -903.65% | -58.72% | 173.59% | 986.36% |
| Cash from Operations | -24.56% | -30.75% | -44.66% | 1.83% | -10.02% |
| Capital Expenditure | -- | -355.56% | -- | 84.09% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 24.51% | 231.82% | -121.98% | -427.40% | -198.10% |
| Cash from Investing | 21.75% | 231.63% | -121.98% | -427.92% | -198.10% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | 40.00% | -120.83% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -100.00% | -431,800.00% | -- |
| Cash from Financing | -- | 512.88% | 1,230.85% | 6,468,150.00% | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -8.37% | 1,107.19% | -333.00% | 30.01% | -326.04% |